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ABSTRACT
Wilson’s disease (WD) is an inherited autosomal genetic abnormality which results in impairment in cellular copper transport. Overtime, this may 
lead to liver cirrhosis. The main focus of this case is to shows the importance of taking a medical history. Here, we discuss a case of a 35-year-old male 
diagnosed with WD-induced liver cirrhosis and portal hypertension. He was physically very weak. Since the same genetic abnormality was the reason 
for the death of his sibling which was not considered while taking the medical history of this patient, this led to a late diagnosis of 4 years while the 
patient’s condition became worst. Herein, we report a case that provides an insight to medical professionals about taking proper medical history of 
patients
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INTRODUCTION
Wilson’s disease (WD) is an autosomal recessive disorder caused by 
a mutation in the ATP7B gene involving liver and brain and which 
results in impairment of biliary excretion of copper. About 47% and 
55% of cases reported have positive family history and consanguinity, 
respectively [1]. A patient (5-40 years old) presenting with liver 
disease, with a decrease in the level of serum ceruloplasmin, and 
detectable Kayser–Fleischer (KF) rings in eyes are the main symptoms 
of WD [2]. Delay in diagnosis of WD is observed across all the health-
care levels [3]. WD will be fatal unless diagnosed in time. The main 
complications of WD include brain damage and liver cirrhosis, 
psychiatric disturbances, i.e., depression, suicidal tendencies, and 
aggressive behavior motor dysfunction and corneal opacities [4]. The 
following case report illustrates the importance of taking the proper 
medical history of patients presenting with different clinical conditions.
CASE REPORT
A 35-year-old male presented with severe pain, abdominal distension, 
and vomiting. He had a history of intermittent hematochezia over 
the past 2 months and also his relatives had noticed a change in the 
patient’s behavior (easily irritable) over the past 1 month. Initially, 
patient could perform his routine daily activities without any hesitation, 
but for the past 1 month, he found it to be difficult. He had no history of 
limb weakness, headache, seizures, difficulty in swallowing, chewing, 
and drinking water and also no history of any major illness or any 
major surgery. Birth history and vaccination history are normal. He 
was previously admitted and evaluated at 2-3 hospitals where he was 
diagnosed to have liver cirrhosis. Treatment for cirrhosis was given, but 
no progress was observed in his condition. Finally, he was referred to our 
tertiary care hospital. While taking patient history, we found out that he 
had a consanguineous marriage and also his brother died at a young age 
due to WD. Hence, we send investigations for WD, serum ceruloplasmin 
was found to be low, 24 hrs urine copper values was 75 mcg, and he 
was found to have KF rings in both eyes in ophthalmology consultation. 
Thus, he was diagnosed to have WD-induced liver cirrhosis with portal 
hypertension. He had Child–Pugh score C and model of end-stage liver 
disease score 23. Patient was having ascites but no signs of spontaneous 
bacterial peritonitis. He was started with WD-specific treatment, tablet 
Penicillamine 250 mg, tablet Ascazin (50 mg elemental zinc), tablet 
Udiliv 300 mg, tablet Rifagut 250 mg, Syrup Looz 30 ml, and other 
hepatoprotective drugs. However, due to late diagnosis, his condition 
became worst, and finally, liver transplantation was the last option. 
Later, his liver transplantation was done where his wife was the donor. 
To prevent rejection, T Azoran 100 mg/day and T Everolimus 0.25 mg 
were started. He had a positive response to treatment and is under 
recovery now.
DISCUSSION
WD or hepatolenticular degeneration is an autosomal recessive genetic 
disorder, in which copper accumulates in tissues. It is found all over the 
world, with a prevalence rate of approximately 1 in 30,000 live births in 
most populations. Since there is a decrease in biliary copper excretion, 
it leads to accumulation of copper in several organs, mostly the liver, 
brain, and cornea. Overtime, it may lead to liver cirrhosis. A small 
percent of patients found to develop acute liver failure, most often in 
the setting of advanced fibrosis of the liver. In addition, some patients 
may develop neurologic complications, which can be fatal. The chance 
of sibling and offspring being a homozygote and developing clinical 
disease is 25% and 0.5%, respectively. There is a higher incidence rate 
in Asians is attributed to consanguinity. In India, the prevalence rate is 
not performed because of the paucity of studies; however, it is relatively 
common in South India because of more consanguineous marriage 
(55%). In India, there are less community-based incidence and reports 
(many are hospital based reports) although variation in epidemiology, 
clinical presentation, and course is reported [4].
In this case, patient’s condition becomes worst due to late diagnosis 
of WD. If proper history taking was done, there would be more 
chance of early diagnosis because he had a consanguineous marriage 
and his brother died due to WD. In WD, there is a failure of copper 
binding to ceruloplasmin. Hence, hepatic synthesis and secretion of 
ceruloplasmin protein without copper give rise to apoceruloplasmin, 
which has decreased half-life compared with ceruloplasmin resulting 
in decreased serum ceruloplasmin in WD. Over accumulation of copper 
in hepatocells leads to spill into circulation and thus increases the 
copper content in blood and get deposited in various organs such as 
brain, kidney, cornea, and skeletal system [5]. Patient was treated for 
WD with D-penicillamine; it contains a free sulfhydryl group which acts 
as a copper chelating moiety. It helps to remove copper from less tightly 
bound sites on proteins, peptides, and membranes and promotes its 
urinary excretion. Along with that oral zinc supplements were given 
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which interfere in copper absorption, providing a rationale for its 
use in WD. Zinc induces metallothionein (an endogenous chelator of 
metals) in enterocytes, which has a higher affinity for copper than for 
zinc, thus binds with the luminal copper and prevent it from entering 
into circulation. The bound copper is excreted fecally during normal 
turnover of enterocytes [6].
The main focus of this case is to show the importance of taking a 
medical history. Since the same genetic abnormality was the reason 
for the death of his elder sibling which was not considered before 
and this led to a late diagnosis. Similar case report “WD: A clinical 
autopsy case report with review of literature” also points out the 
importance of a premedication history that may avoid the delay in 
getting abrupt care and which can improve the patient condition and 
prevent fatality.
CONCLUSION
The patient assessment should be entertained with a premedication 
history presenting with liver dysfunction and/or extrapyramidal 
neurological features. This case also points to the importance of 
taking the proper medical history of the patients for providing better 
treatment and to improve the quality of life of the patients.
REFERENCES
1. Meenakshi-Sundaram S, Mahadevan A, Taly AB, Arunodaya GR, 
Swamy HS, Shankar SK. Wilson’s disease: A clinico-neuropathological 
autopsy study. J Clin Neurosci 2008;15(4):409-17.
2. Roberts EA, Schilsky ML; American Association for Study of Liver 
Diseases (AASLD). Diagnosis and treatment of Wilson disease: An 
update. Hepatology 2008;47(6):2089-111.
3. Stefano V, Lionetti E, Rotolo N, La RM, Leonardi S. Hypercalciuria and 
nephrocalcinosis as early feature of Wilson disease onset: Description 
of a pediatric case and literature review. Hepat Mon 2012;12(8):e6233.
4. Bandyopadhyay D, Ghosh D, Chattopadhyay A, Mitra E. Curry leaves 
as alternative medicine in heavy metal induced occupational health 
hazards. Int J Pharm Pharm Sci 2016;8(8):8-20.
5. Raju K, Bangalore GN, Thuruvekere SN, Pathavanalli VN. Wilson’s 
disease: A Clinical autopsy case report with review of literature. J Nat 
Sci Biol Med 2015;6(1):248-52.
6. Egberto R, Alexandre A, Costa M, Eduardo L, Rachid C, Marta M. 
Wilson’s Disease: A case report and a historical review. Arq 
Neuropsiquiatr 2009;67(2-B):539-43.
Table 1: Significant laboratory investigation parameters of the 
present case
Lab investigations Result Normal levels
Haemoglobin 9.66 g/dl 13.0-17.0 g/dl
Platelets 115 K/uL 150.0-450.0 K/uL
Prothrombin/partial 
thromboplastin time
14.60 seconds 11-14 seconds
Total bilirubin 4.20 mg/dl 0.2-1.2 mg/dl
Serum albumin 1.83 g/dl 3.5-5.2 g/dl
Total protein 7.64 g/dl 6.6-8.3 g/dl
Blood urea 29.9 mg/dl 17.0-43.0 mg/dl
Serum creatinine 1.16 mg/dl 0.84-1.4 mg/dl
SGOT 153.1 IU/L 5.0-35.0 IU/L
SGPT 69.4 IU/L 5.0-45.0 IU/L
Alkaline phosphatase 102.5 IU/L 13.0-120.0 IU/L
SGOT: Serum glutamic oxaloacetic transaminase, SGPT: Serum glutamic pyruvic 
transaminase
